Brachytherapy Seeds Market Size is valued at USD 137.7 Mn in 2024 and is predicted to reach USD 224.1 Mn by the year 2034 at a 5.2% CAGR during the forecast period for 2025-2034.
Brachytherapy seeds, often used in permanent brachytherapy, are small radioactive pellets implanted directly into or near tumors to deliver localized radiation therapy. These seeds, typically the size of a grain of rice, contain radioactive isotopes such as iodine-125 or palladium-103, which emit low-energy photons to kill cancer cells over time. The seeds are placed into the tumor site using needles that are guided by imaging techniques such as ultrasound or CT scans. This provides that the radiation is delivered accurately to the tumor site, while simultaneously minimizing the exposure of the adjacent healthy tissue. The radioactivity of the seeds gradually decreases as they decay, usually over several months, and the seeds remain in place permanently
The focused treatment and shortened duration of this method makes it a popular choice for malignancies such as prostate, breast, cervical, and skin cancers. The business component of this cancer treatment is the primary focus of the brachytherapy seed market. Brachytherapy devices, including apparatus and associated products, are manufactured and distributed by companies. The market size is contingent upon the prevalence of cancer, technological advancements, and the public's awareness of the advantages of brachytherapy seed. Medical device manufacturers, healthcare providers, research institutions comprise significant stakeholders.
However, a restraining factor may be the absence of awareness among healthcare professionals as well as patients regarding the advantages of brachytherapy seed. Furthermore, the market's expansion may be hindered by the restricted availability of brachytherapy facilities in specific regions. The initial setup & maintenance costs of brachytherapy apparatus can be prohibitive for lesser healthcare facilities. The expansion of the market in particular areas is restricted by the high cost of technology and the necessity of specialized training, which creates barriers to entry. The strict regulatory approval processes and compliance standards can impede the introduction of novel brachytherapy technologies and products. This regulatory complexity has the potential to inhibit market growth and innovation.
• Argon Medical
• Carl Zeiss AG
• Eckert & Ziegler BEBIG
• Elekta AB
• Icad, Inc.
• Isoaid
• Isoray Medical, Inc.
• Merit Medical Systems, Inc.
• Siemens AG
• Theragenics Corporation
• Other Market Players
The Brachytherapy Seeds market is segmented by radioactive seed type, techniques, application, and end-user. Based on radioactive seed type, the market is segmented into iodine, Palladium-103, Cesium-131, and others. By technique, the market is segmented into HRD Brachytherapy and LDR Brachytherapy. By application, the market is classified into gynaecological cancer, prostate cancer, breast cancer, brain cancer, and others. The end-user segment includes hospitals, cancer institutes, and others.
In 2024, the prostate cancer segment dominated the brachytherapy seed market. The prostate cancer brachytherapy industry is anticipated to experience significant growth as a result of its numerous advantages over other forms of treatment. This method offers key advantages such as higher tumor dose with minimal impact on surrounding organs, shorter treatment time, quicker recovery, low risk of side effects due to precise radiation delivery, and effectiveness in treating recurrent prostate cancer.
HRD Brachytherapy Segment Witness Growth At A Rapid Rate HDR Brachytherapy dominates the global market. It entails the utilization of a remote after-loading system to deliver a high dosage of radiation to the tumour site. HDR Brachytherapy's dominance is driven by its flexibility to tailor treatment plans, precise radiation delivery, shorter procedure times, and enhanced patient comfort. Technological advancements such as improved imaging, treatment planning, and after-loaders enable real-time visualization and accurate tumor targeting, making it effective for various cancer types.
In The Region, The North America Brachytherapy Seeds Market Holds A Significant Revenue Share.
The healthcare sector's ongoing technological advancements are the primary driver of the Brachytherapy seeds Market in North America. The region's commitment to innovation, in conjunction with significant investments in research and development, has resulted in state-of-the-art brachytherapy solutions that cater to a wide variety of medical requirements. The increased prevalence of cancer in North America has resulted in a greater demand for targeted treatments, such as brachytherapy.
The region's market dominance is being driven by the growing awareness of the therapy's benefits among patients and healthcare professionals. The seamless integration of brachytherapy into existing treatment protocols is facilitated by the well-established healthcare infrastructure of North America, which includes sophisticated medical facilities and skilled professionals. This supportive environment reinforces the region's market leadership by utilizing state-of-the-art facilities and sophisticated diagnostic capabilities to improve cancer treatment options.
• In March 2024, Eckert & Ziegler BEBIG GmbH, a subsidiary of Eckert & Ziegler SE specializing in brachytherapy solutions for treating prostate, brain, and ocular cancers, achieved a significant milestone by obtaining the Medical Device Regulation (MDR) certificate for its proprietary prostate seeds from DEKRA Certification B.V.. This certification ensures a high level of patient safety and guarantees the long-term availability of these seeds within the European Union.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 137.7 Million |
|
Revenue Forecast In 2034 |
USD 224.1 Billion |
|
Growth Rate CAGR |
CAGR of 5.2% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Radioactive Seed Type, Techniques, Application, And End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; Germany; China; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia |
|
Competitive Landscape |
Argon Medical, Carl Zeiss AG, Eckert & Ziegler BEBIG, Elekta AB, Icad, Inc., Isoaid, Isoray Medical, Inc., Merit Medical Systems, Inc., Siemens AG, Theragenics Corporation. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Brachytherapy Seeds Market Snapshot
Chapter 4. Global Brachytherapy Seeds Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Brachytherapy Seeds Market Industry Trends
4.10. Global Brachytherapy Seeds Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Brachytherapy Seeds Market Segmentation 1: By Radioactive Seed Type, Estimates & Trend Analysis
5.1. Market Share by Radioactive Seed Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Radioactive Seed Type:
5.2.1. Iodine-125
5.2.2. Palladium-103
5.2.3. Cesium-131
5.2.4. Others
Chapter 6. Brachytherapy Seeds Market Segmentation 2: By Technique, Estimates & Trend Analysis
6.1. Market Share by Technique, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technique:
6.2.1. HRD Brachytherapy
6.2.2. LDR Brachytherapy
Chapter 7. Brachytherapy Seeds Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share by Application, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
7.2.1. Gynecological Cancer
7.2.2. Prostate Cancer
7.2.3. Breast Cancer
7.2.4. Brain Cancer
7.2.5. Others
Chapter 8. Brachytherapy Seeds Market Segmentation 4: By End-user, Estimates & Trend Analysis
8.1. Market Share by End-user, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-user:
8.2.1. Hospitals
8.2.2. Cancer Institutes
8.2.3. Others
Chapter 9. Brachytherapy Seeds Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Brachytherapy Seeds Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Radioactive Seed Type, 2021-2034
9.2.3. North America Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2021-2034
9.2.4. North America Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.5. North America Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.3. Europe
9.3.1. Europe Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Radioactive Seed Type, 2021-2034
9.3.3. Europe Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2021-2034
9.3.4. Europe Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.5. Europe Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Radioactive Seed Type, 2021-2034
9.4.3. Asia Pacific Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2021-2034
9.4.4. Asia Pacific Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.5. Asia Pacific Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.5. Latin America
9.5.1. Latin America Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Radioactive Seed Type, 2021-2034
9.5.3. Latin America Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2021-2034
9.5.4. Latin America Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.5. Latin America Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Radioactive Seed Type, 2021-2034
9.6.3. Middle East & Africa Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2021-2034
9.6.4. Middle East & Africa Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.5. Middle East & Africa Brachytherapy Seeds Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Argon Medical
10.2.1.1. Business Overview
10.2.1.2. Key Solution/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.3. Carl Zeiss AG
10.4. Eckert & Ziegler BEBIG
10.5. Elekta AB
10.6. Icad, Inc.
10.7. Isoaid
10.8. Isoray Medical, Inc.
10.9. Merit Medical Systems, Inc.
10.10. Siemens AG
10.11. Theragenics Corporation
Brachytherapy Seeds Market By Radioactive Seed Type-
• lodine-125
• Palladium-103
• Cesium-131
• Others
Brachytherapy Seeds Market By Technique-
• HRD Brachytherapy
• LDR Brachytherapy
Brachytherapy Seeds Market By Application-
• Gynecological Cancer
• Prostate Cancer
• Breast Cancer
• Brain Cancer
• Others
Brachytherapy Seeds Market By End-user-
• Hospitals
• Cancer Institutes
• Others
Brachytherapy Seeds Market By Region-
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
